RSS
21 Feb 2021

Gannex Announces Positive Clinical Results in Overweight and Obese Subjects for Its THR-β Agonist ASC41

Author: admintech | Filed under: Press Release

SHANGHAI, Feb. 21, 2021 /PRNewswire/ — Gannex, a wholly owned company of Ascletis Pharma Inc. (HKEX: 1672), fully dedicated to the R&D and commercialization of new drugs in the field of nonalcoholic steatohepatitis (NASH), announces the positive clinical results in overweight and obese…

This entry was posted on Sunday, February 21st, 2021 at 7:17 am and is filed under Press Release. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

«

»